Skip to main content
    H

    Humana Inc (HUM)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $461.15
    +11.15 (+2.48%)

    Market Cap: $54.05B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Humana Inc (HUM) Financials: Revenue, Profit and Cash Flow

    Updated Nov 6, 2026. Financial statements from company filings, amounts in US dollars.

    Humana reported revenue of $129.66B for the fiscal year ended Dec 31, 2025, up 10.1% from the year before. That year, net income was $1.20B with a net margin of 0.9%, operating cash flow was $921.00M and free cash flow was $375.00M. The quarter ended Sep 30, 2026 had revenue of $41.16B and net income of $161.00M.

    Revenue and Margins

    The operating margin was 2.1% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $54.38B, a compound annual rate of 10.1%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$129.66B+10.1%14.5%2.1%0.9%
    Dec 2024$117.76B+10.7%14.5%2.2%1.0%
    Dec 2023$106.37B+14.5%16.9%3.8%2.3%
    Dec 2022$92.87B+11.8%18.5%4.1%3.0%
    Dec 2021$83.06B+7.7%16.7%3.8%3.5%
    Dec 2020$77.16B+18.9%20.1%6.5%4.4%
    Dec 2019$64.89B+14.0%17.0%4.9%4.2%
    Dec 2018$56.91B+5.8%19.4%5.4%3.0%
    Dec 2017$53.77B-1.1%19.1%7.9%4.6%
    Dec 2016$54.38BN/A17.2%3.2%1.1%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income fell 0.8% from the year before. In the quarter ended Sep 2026, net income fell 17.0% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$129.66B$117.76B$106.37B$92.87B$83.06B$77.16B$64.89B$56.91B$53.77B$54.38B
    Cost of revenue$110.81B$100.66B$88.39B$75.69B$69.20B$61.63B$53.86B$45.88B$43.50B$45.01B
    Gross profit$18.85B$17.10B$17.98B$17.18B$13.87B$15.53B$11.03B$11.03B$10.27B$9.37B
    Operating income$2.70B$2.56B$4.01B$3.80B$3.15B$4.99B$3.19B$3.10B$4.26B$1.74B
    Net income$1.20B$1.21B$2.48B$2.80B$2.93B$3.37B$2.71B$1.68B$2.45B$614.00M
    EBITDA$3.01B$3.35B$4.79B$4.81B$4.39B$5.50B$4.27BN/A$4.75B$2.21B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$41.16B$40.87B$39.65B$32.52B$32.65B$32.39B$32.11B$29.21B$29.40B$29.54B$29.61B$26.46B
    Gross profit$4.83B$5.50B$5.94B$3.79B$4.66B$4.82B$5.58B$3.83B$4.28B$4.50B$4.49B$3.68B
    Operating income$75.00M$1.36B$1.75B-$808.00M$400.00M$1.10B$2.01B-$543.00M$728.00M$1.14B$1.24B-$348.00M
    Net income$161.00M$693.00M$1.18B-$776.00M$194.00M$543.00M$1.24B-$683.00M$480.00M$678.00M$739.00M-$540.00M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $12.37B exceeded cash and equivalents by $8.17B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$48.91B$46.48B$47.06B$43.05B$44.36B$34.97B$29.07B$25.41B$27.18B$25.40B
    Current assets$32.73B$29.82B$29.99B$26.18B$24.89B$23.64B$19.89B$16.95B$17.40B$16.19B
    Cash and equivalents$4.20B$2.22B$4.69B$5.06B$3.39B$4.67B$4.05B$2.34B$4.04B$3.88B
    Total liabilities$31.17B$30.03B$30.75B$27.68B$28.25B$21.24B$17.04B$15.25B$17.34B$14.71B
    Short-term debt$0$577.00M$1.44B$2.09B$1.95B$600.00M$699.00M$1.69B$291.00M$512.00M
    Long-term debt$12.37B$11.14B$10.21B$9.03B$10.54B$6.06B$4.97B$4.38B$4.77B$3.79B
    Shareholder equity$17.66B$16.38B$16.26B$15.31B$16.08B$13.73B$12.04B$10.16B$9.84B$10.69B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$57.28B$57.20B$55.28B$48.75B$49.72B$50.36B$50.93B$46.31B$50.01B$50.09B$50.09B$46.89B
    Total liabilities$38.40B$37.92B$36.63B$31.01B$31.14B$32.06B$33.11B$29.87B$32.38B$33.37B$33.91B$30.57B
    Cash and equivalents$6.93B$6.89B$4.95B$4.20B$5.39B$4.04B$4.25B$2.22B$5.12B$5.50B$5.91B$4.69B
    Shareholder equity$18.82B$19.21B$18.58B$17.66B$18.52B$18.23B$17.75B$16.38B$17.57B$16.67B$16.13B$16.26B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 40.7% of operating cash flow. Dividends and share repurchases together came to 154.9% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$921.00M$2.97B$3.98B$4.59B$2.26B$5.64B$5.28B$2.17B$4.05B$1.94B
    Capital expenditures$546.00M$575.00M$1.00B$1.14B$1.34B$964.00M$736.00M$612.00M$524.00M$527.00M
    Free cash flow$375.00M$2.39B$2.98B$3.45B$920.00M$4.67B$4.55B$1.56B$3.53B$1.41B
    Dividends paid$430.00M$431.00M$431.00M$392.00M$354.00M$323.00M$291.00M$265.00M$220.00M$177.00M
    Share repurchases$151.00M$817.00M$1.57B$2.10B$79.00M$1.82B$1.07B$1.09B$3.37B$104.00M
    Investing cash flow$2.27B-$2.95B-$3.49B-$1.01B-$6.56B-$3.06B-$1.28B-$3.09B-$2.94B-$1.36B
    Financing cash flow-$1.22B-$2.49B-$856.00M-$1.91B$3.02B-$1.96B-$2.29B-$785.00M-$945.00M$732.00M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$2.16B$1.97B$1.25B-$1.65B$971.00M$1.27B$331.00M-$528.00M$1.86B$1.21B$423.00M-$7.13B
    Capital expenditures$137.00M$132.00M$121.00M$202.00M$135.00M$114.00M$95.00M$154.00M$130.00M$114.00M$177.00M$283.00M
    Free cash flow$2.03B$1.83B$1.13B-$1.85B$836.00M$1.16B$236.00M-$682.00M$1.73B$1.10B$246.00M-$7.42B
    Last 12 quarters

    Frequently Asked Questions About HUM

    What is Humana's annual revenue?

    Humana reported revenue of $129.66B for the fiscal year ended Dec 31, 2025.

    How fast is Humana's revenue growing?

    Revenue was up 10.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 11.8%.

    Is Humana profitable?

    Yes. Humana reported net income of $1.20B for the fiscal year ended Dec 31, 2025, with a net margin of 0.9%.

    How much free cash flow does HUM generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $921.00M minus capital expenditures of $546.00M produced free cash flow of $375.00M.

    How much debt does Humana have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $12.37B, short-term debt of $0 and cash and equivalents of $4.20B.